MAPT and Alzheimer disease: A study performed on HEK293/Tau cells pretreated with Physalin B demonstrates that phosphorylation levels of tau at sites involved in AD onset, like S404, S262, and T231 decreased significantly through the inhibition of GSK‐3β and ERK.[189]